This commentary proposes a hybrid drug pricing reform model balancing most favored nation (MFN) benchmarking with domestic negotiation strategies that drive equity-focused valuation frameworks.

A new study claims a certified registered nurse anesthetist working as the sole anesthesia provider is the most cost-effective model of anesthesia delivery and doesn’t impact care quality, according ...

Several new treatment combinations have been approved in metastatic renal cell carcinoma (mRCC). To determine the optimal therapy on the basis of cost and health outcomes, we performed a ...

A joint model combining decision tree with partitioned survival models was developed. A two-round consensus panel was performed to describe clinical practice of Spanish reference centers, providing ...

Treatment with abelacimab could result in potential cost-savings of $50,000 over a lifetime per patient basis and higher quality-adjusted life years in atrial fibrillation patients at a high risk of ...

Salpingectomy for permanent contraception yields an incremental cost-effectiveness ratio of $143,769 per quality-adjusted ...

Chinese artificial intelligence (AI) startup MoonShot AI is expected to secure an investment valuing the company at $4 ...

AWS CEO Matt Garman’s keynote at AWS re:Invent 2025 in Las Vegas on Tuesday focused on the $132 billion cloud leader’s new ...